lobbying_activities: 2955050

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2955050	672115f8-d2e2-48d6-94e4-a4aacb87926b	Q1	WATKINS & EAGER PLLC	401104403	ZYNERBA PHARMACEUTICALS, INC.	2023	first_quarter	GOV	Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome.	HOUSE OF REPRESENTATIVES,SENATE	15000		0	0	2023-04-05T11:19:18-04:00